Medical Device News Magazine

3D Imaging Software: The Future of Shoulder Arthroplasty in the Digital Era: By Brent Narkiewicz VP of Catalyst

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

While knee and hip surgeries continue to top the charts in terms of the sheer number of arthroplasty procedures performed in the U.S., the shoulder segment is projected to see a compound annual growth rate of 8.7% from 2017 to 2022, with increases in reverse shoulder and anatomic shoulder procedures largely contributing to the upward trend. In particular, we’ve seen explosive growth in the number of reverse shoulder procedures, primarily performed as a method of treating severely damaged rotator cuffs.

By next year, the size of the total U.S. shoulder market is expected to reach over $1.4 billion. And, given that both the rising aging population is looking to stay active well into their retirement years, and the many advancements in shoulder arthroplasty has allowed it to be one of the most reliable treatment options for degenerative joint disease of the shoulder, this trend is likely to continue for some time.

That upward trajectory represents exciting opportunities, particularly as providers look to rebound from slowdowns in elective surgeries over the last 2 years. To meet burgeoning market demands and accelerate growth, med-tech partnerships that enable the use of 3D imagining software have become critically important. Indeed, this technology is increasingly considered an essential tool for today’s arthroplasty surgeon.

The value of 3D imaging is hard to deny. Not only does a 3D image help enhance preoperative shoulder arthroplasty planning, minimizing real-time surprises and changes, but it also aids in interoperative navigation and decision-making that ultimately results in more accurate placement of implants. In other words, this software is designed with both the patient and the physician experience in mind, and surgeons are quickly finding that 3D imaging is making their lives easier and their procedures more efficient than traditional two-dimensional CT scans alone.

“3D planning has completely changed my approach to planning for my shoulder arthroplasty cases,” said Matthew A. Kippe, MD, sports medicine and shoulder surgeon, Hawthorn Medical Associates in  North Dartmouth, MA.  “I can now better understand the deformity associated with certain arthritic conditions and more accurately place components in order to ensure better functional outcomes and perhaps improve longevity.”

And the benefits of this technology will continue to build. In addition to the speed and accuracy it offers today, the software is also laying the groundwork for even more efficient surgeries down the road. As more patient data gets uploaded and captured by the system, the database grows, and our AI gains more intelligence.

What’s more, it’s becoming a matter of talent acquisition and retention. Today’s up-and-coming clinicians who are just starting their medical careers are now being trained with this technology, and they expect to be able to use it in the field.

At Catalyst OrthoScience, we know this software is simply a must-have in med-tech. That’s why, earlier this year, we introduced a preview of Archer™ 3D Targeting – imaging software designed to support preoperative planning for shoulder arthroplasty. Licensed in partnership with 3D-Shoulder, a subsidiary of 3D-Side, Archer 3D Targeting utilizes decades of shoulder experience to help surgeons gain a better understanding of the patient’s pathology and create a surgical plan in advance of the procedure.

The system uses a two-dimensional image, such as a CT scan, which nearly all surgeons order in the course of diagnosis and pre-op prep. Once the surgeon uploads the imaging, a plan with data-driven recommendations on how best to place the implants is produced, and the surgeon can review and adjust the plan as needed before finalizing. Particularly as today’s surgeons address more complex shoulder pathologies, this latest innovation offers a heightened degree of clarity and precision, making it an invaluable addition to the surgeon’s comprehensive set of tools and solutions.

“I think it is essential for adding Archer 3D Targeting software to Catalyst’s Archer portfolio, as it is quickly becoming the standard of care for planning shoulder arthroplasty surgeries” said Dr. Kippe.  “Most surgeons are currently using some type of planning software and I see it as essential for the growth of the prosthesis.”

Catalyst also recognizes the power of this software to launch a new generation of arthroplasty innovation well into the future. We’re leaning into this technology, knowing full well it will come back around to help inform new implant device design and better preoperative guides. The more this 3D imaging software is used, the more data there is to fuel AI-driven procedure improvements – ultimately helping to pave the way for a new era of precision medicine that’s just beginning to dawn.

 

 

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”